<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="10.4103/1817-1745.106470 : Original Article Effective dose of topiramate in pediatric" exact="migraine" post="prophylaxis Abbaskhanian Ali Sadeghi Hamid Reza Erfani Ali Rezai"/>
 <result pre="work is properly cited. Abstract Objective: Migraine is a common" exact="neurological disorder" post="in childhood and adolescence. Topiramate is a new anticonvulsant"/>
 <result pre="Topiramate is a new anticonvulsant drug, recently being used in" exact="migraine" post="prophylaxis in adults, although it is not approved by"/>
 <result pre="performed to evaluate the efficacy of low-dose topiramate in pediatric" exact="migraine" post="prophylaxis. Materials and Methods: A prospective study, including 60"/>
 <result pre="Materials and Methods: A prospective study, including 60 patients with" exact="migraine" post="headaches was performed for a period of two months."/>
 <result pre="0.7 mg/kg/day) showed a reduction in the mean (±SD) of" exact="migraine" post="frequency from 6.2 (±2.4) to 3.0 (±1.8) episodes per"/>
 <result pre="suggested as an alternative prophylactic treatment for pediatric migraine. Pediatric" exact="migraine" post="prophylaxis topiramate Introduction Migraine is a common neurological disorder"/>
 <result pre="migraine. Pediatric migraine prophylaxis topiramate Introduction Migraine is a common" exact="neurological disorder" post="in childhood and adolescence. It has a prevalence of"/>
 <result pre="times more common in girls.[ 1 2] Management of pediatric" exact="migraine" post="includes lifestyle changes (in order to avoid foods, habits"/>
 <result pre="avoid foods, habits or environmental factors that may trigger a" exact="migraine" post="attack), the use of abortive medications, and preventive measures,"/>
 <result pre="3 4] Topiramate has been shown to be effective for" exact="migraine" post="prevention in adults. Limited data is available for the"/>
 <result pre="mechanism of topiramate is unknown.[ 6] It is proposed that" exact="epilepsy" post="and migraine share some of the same pathophysiological mechanisms,"/>
 <result pre="topiramate is unknown.[ 6] It is proposed that epilepsy and" exact="migraine" post="share some of the same pathophysiological mechanisms, including abnormal"/>
 <result pre="uncontrolled studies done to evaluate the efficacy of topiramate in" exact="migraine" post="prophylaxis especially in refractory causes confirmed that it could"/>
 <result pre="causes confirmed that it could be effective in prophylaxis of" exact="migraine" post="headache.[ 5 9] Data to support the effectiveness, tolerability,"/>
 <result pre="performed to evaluate the efficacy of low-dose topiramate in pediatric" exact="migraine" post="prophylaxis. Materials and Methods The study was designed as"/>
 <result pre="15 years of age) treated with topiramate for prevention of" exact="migraine" post="headaches, at a pediatric neurology clinic in north of"/>
 <result pre="from March 2011 through September of 2011. The diagnosis of" exact="migraine" post="was based on 2005 definition by the International Headache"/>
 <result pre="and patients were asked baseline laboratory screening tests and a" exact="migraine" post="checklist, including demographic and clinical details of the patients"/>
 <result pre="criteria were as follows: Prior or current prophylactic treatment for" exact="migraine" post="in the last two months Persistent increasing headache Change"/>
 <result pre="adverse effects, using the Student′s t test. The incidence of" exact="migraine" post="attacks and adverse effects before and after treatment was"/>
 <result pre="are recorded [ Table 1]. Frequency intensity and duration of" exact="migraine" post="headache decreased significantly between repeated follow-up visits of each"/>
 <result pre="migraines require prophylactic therapy.[ 14] The successful treatment of pediatric" exact="migraine" post="includes an individually tailored regimen of both non pharmacologic"/>
 <result pre="recommended, if possible.[ 14] Many treatments are currently used for" exact="migraine" post="prophylaxis, including β-blockers, calcium channel antagonists, serotonin antagonists, antidepressants"/>
 <result pre="and performed to compare different dosage of topiramate in pediatric" exact="migraine" post="prophylaxis. In our study, the mean dose in patients"/>
 <result pre="al.[ 21] evaluated the efficacy and safety of topiramate for" exact="migraine" post="prevention in pediatric subjects aged 12-17 years. They found"/>
 <result pre="mg/day, resulted in a statistically significant reduction in the monthly" exact="migraine" post="attack rate from baseline versus placebo (median, 72.2% vs."/>
 <result pre="22] presented that effective mean dose of topiramate in pediatric" exact="migraine" post="prophylaxis is 3.5 ± 1.7 mg/kg/day. The results of"/>
 <result pre="with topiramate for 4 months. And recorded a reduction in" exact="migraine" post="frequency but this was not significantly different from baseline"/>
 <result pre="was not significantly different from baseline and significant differences in" exact="migraine" post="severity and duration of the episodes. Our study revealed"/>
 <result pre="et al.[ 9] reported that 28 (76%) of children with" exact="migraine" post="had an excellent or good response to topiramate. Topiramate"/>
 <result pre="RB Validity of family history data on severe headache and" exact="migraine" post="Neurology 1993 43 1954 60 8413952 3 Hershey AD"/>
 <result pre="efficacy of its use in the prevention and treatment of" exact="migraine" post="J Cent Nerv Syst Dis 2011 3 155 68"/>
 <result pre="S et al. Efficacy and tolerability of topiramate in pediatric" exact="migraine" post="Pediatr Neurol 2009 41 167 70 19664530 10 Olesen"/>
 <result pre="and a clinical, psychological and encephalographic comparison between children with" exact="migraine" post="and matched control Acta Paediatr Suppl 1962 51 1"/>
 <result pre="1962 51 1 151 13869189 12 Sillanpaa M Prevalence of" exact="migraine" post="and other headache in finnish children starting scho Headache"/>
 <result pre="14 Eiland LS Anticonvulsant use for prophylaxis of the pediatric" exact="migraine" post="J Pediatr Health Care 2007 21 392 5 17980806"/>
 <result pre="Diamond S Scott D Jones V Prophylactic treatment of pediatric" exact="migraine" post="Headache 2004 44 230 7 15012660 16 French JA"/>
 <result pre="Silberstein SD Neto W Schmitt J Jacobs D Topiramate in" exact="migraine" post="prevention: Results of a large controlled trial Arch Neurol"/>
 <result pre="Seggern RL Mannix LK Adelman JU Efficacy of topiramate in" exact="migraine" post="prophylaxis: A retrospective chart analysis Headache 2002 42 804"/>
 <result pre="Wang S Yuen E Battisti WP et al. Topiramate for" exact="migraine" post="prevention in adolescents: A pooled analysis of efficacy and"/>
 <result pre="study to evaluate the efficacy and safety of topiramate for" exact="migraine" post="prevention in pediatric subjects 12-17 years of age Pediatrics"/>
 <result pre="Casas C Herranz JL Topiramate in the prophylactic treatment of" exact="migraine" post="in children J Child Neurol 2005 20 251 3"/>
</results>
